Nicole Willmarth

Results:

ABTA 50th Anniversary
Colleen O'Malley

ABTA Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research

The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages. Dedicated to advancing the field of neuro-oncology and accelerating the discovery of life-saving treatments, the ABTA is proud to have invested more than $35 million, to approximately 700 researchers to support 800 projects, to date.

Learn More »
Colleen O'Malley

American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries

The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments. With more than $34 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing the understanding of brain tumors and building the next generation of brain tumor researchers.

Learn More »
Colleen O'Malley

American Brain Tumor Association Awards 17 Research Grants

The American Brain Tumor Association (ABTA) today announced the funding of $427,000 towards 17 new 2021 research grants to improve brain tumor science and discovery. With more than $33.5 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing treatments and ushering in the next generation of brain tumor researchers.

Learn More »
Colleen O'Malley

ABTA SURVEY FINDS DISPARITIES IN CARE OF PATIENTS WITH METASTATIC BRAIN TUMORS

A first-of-its-kind, cross-sectional survey of patients, caregivers and physicians on the diagnosis and treatment of brain metastases, conducted by the American Brain Tumor Association (ABTA), as part of its Metastatic Brain Tumor Initiative, revealed disparities in practice patterns and communication around metastatic brain tumors. These data highlight the need to increase accessibility to clinical trials, establish clear standards of care and improve physician-patient communication reflective of the unique needs of patients with brain metastases (BM). The survey results have been published open access in the journal Neuro-Oncology Practice.

Learn More »